Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 8.27 BATS BZX Real-Time Price As of May 20 |  0.00 / 0.00%Today’s Change | 6.00 Today|||52-Week Range 14.40 | -40.29% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Decheng Capital Llc Director |  Buy | 9/17/2021 | 1,542,553 | $9.40 | $14.5M | -17.50% |
Decheng Capital Llc | Buy | 9/17/2021 | 1,542,553 | $9.40 | $14.5M | -17.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 585,106 | $9.40 | $5.5M | -17.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 585,106 | $9.40 | $5.5M | -17.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 425,531 | $9.40 | $4.0M | -17.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 425,531 | $9.40 | $4.0M | -17.50% |
Alpine Bioventures Gp Llc Director |  Sale | 9/17/2021 | 400,000 | $9.40 | $3.8M | -17.50% |
Alpine Bioventures Gp Llc Executive Chairman & Chief Investment Officer | Sale | 9/17/2021 | 400,000 | $9.40 | $3.8M | -17.50% |
Alpine Bioventures Gp Llc | Sale | 9/17/2021 | 400,000 | $9.40 | $3.8M | -17.50% |
Frazier Management Llc | Buy | 2/11/2022 | 112,665 | $7.10 | $799.9K | +12.40% |
Page of 2